Clinical trial
BrainMet ADePPT (Anticancer Drug Penetration Platform Trial)
NCT06807619 is registered in ClinicalTrials.gov with Memorial Sloan Kettering Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- BrainMet ADePPT (Anticancer Drug Penetration Platform Trial)
- Lead sponsor
- Memorial Sloan Kettering Cancer Center
- Phase
- Phase 1
- Overall status
- Recruiting
- Start date
- January 29, 2025
- Completion date
- January 31, 2028
- Enrollment
- 16 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
brain tumor